6733
博晟生醫
-0.40 (-1.57%)25.1579成交張數–本益比3.16股價淨值比0.00%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 11 | 11 | 4.1% | 32.13 | 7.95 | -7.4% | -6.9% | -0.1 | – |
| 2026Q1 | 11 | 11 | 4.1% | 34.37 | 8.75 | -7.2% | -6.7% | -0.1 | – |
| 2025Q4 | 8 | 7 | 7.1% | 17.60 | 5.97 | -10.8% | -9.8% | -0.1 | -0.1 |
| 2025Q3 | 8 | 8 | 7.0% | 18.74 | 6.12 | -12.5% | -11.5% | -0.1 | -0.1 |
| 2025Q2 | 8 | 8 | 6.9% | 21.53 | 6.15 | -15.2% | -14.0% | -0.1 | -0.1 |
| 2025Q1 | 9 | 8 | 6.6% | 25.12 | 6.33 | -16.2% | -14.7% | -0.3 | -0.3 |
| 2024Q4 | 9 | 8 | 7.2% | 21.60 | 6.58 | -13.3% | -11.9% | -0.1 | -0.1 |
| 2024Q3 | 9 | 9 | 6.9% | 25.33 | 7.06 | -11.9% | -10.9% | -0.2 | -0.2 |
| 2024Q2 | 10 | 9 | 6.5% | 30.20 | 7.29 | -12.6% | -11.5% | -0.3 | -0.3 |
| 2024Q1 | 10 | 9 | 6.5% | 36.28 | 7.57 | -11.7% | -10.8% | -0.4 | -0.4 |
| 2023Q4 | 11 | 9 | 8.9% | 17.32 | 7.65 | -19.0% | -16.7% | -0.2 | -0.3 |
| 2023Q3 | 11 | 10 | 6.9% | 34.92 | 7.91 | -20.5% | -18.4% | -0.4 | -0.4 |
| 2023Q2 | 11 | 10 | 7.2% | 31.16 | 8.26 | -20.5% | -18.4% | -0.1 | -0.1 |
| 2023Q1 | 11 | 11 | 6.8% | 39.02 | 8.54 | -20.2% | -18.2% | -0.6 | -0.8 |
| 2022Q4 | 8 | 7 | 11.0% | 17.01 | 6.82 | -23.2% | -20.0% | -0.4 | -0.6 |
| 2022Q3 | 9 | 8 | 8.5% | 25.12 | 7.30 | -17.9% | -16.6% | -0.5 | -0.5 |
| 2022Q2 | 9 | 8 | 7.4% | 39.27 | 7.79 | -15.5% | -14.5% | -0.3 | -0.3 |
| 2022Q1 | 10 | 8 | 7.2% | 43.94 | 8.16 | -15.2% | -14.1% | -0.5 | -0.5 |
| 2021Q4 | 10 | 9 | 7.8% | 29.24 | 8.61 | – | – | -0.3 | -0.3 |
| 2021Q3 | 9 | 9 | 2.7% | 35.80 | 8.56 | – | – | -0.2 | -0.2 |
| 2021Q2 | 9 | 9 | 1.9% | 49.42 | 8.95 | – | – | -0.4 | -0.4 |
| 2021Q1 | 10 | 9 | 2.9% | 30.95 | 9.32 | – | – | -0.3 | -0.4 |